New York Requires Employed Medicaid Recipients To Enroll in Employer-Sponsored Health Insurance
HRD-84-86: Published: Aug 10, 1984. Publicly Released: Aug 10, 1984.
Additional Materials:
- Full Report:
Contact:
(202) 275-6195
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
As a part of its review of the use of recipient health insurance coverage to avoid Medicaid costs, GAO reported on the New York State practice of requiring working recipients to enroll in available employer-sponsored health insurance plans.
GAO found that, if the insurance programs require employee contributions, the state is using Medicaid funds to make contributions to private health insurance programs for employed Medicaid recipients. Even though this practice appears to have the potential for Medicaid savings, the State's imposition of this additional Medicaid eligibility criteria is not permitted by federal law. Such conditions for eligibility are only permissible if the State requests and is granted a waiver from Medicaid requirements for demonstration project purposes.
Recommendation for Executive Action
Status: Closed - Implemented
Comments: HCFA told New York State that its practice was contrary to federal law and to discontinue or modify the practice to bring it into conformance. HCFA instructed states to consider free employer-provided health insurance and state paid premiums for employer-sponsored health insurance as conditions for coverage of services rather than as a condition of elgibility for Medicaid.
Recommendation: The Administrator of the Health Care Financing Administration (HCFA) should direct the New York State Medicaid agency to discontinue the practice of requiring Medicaid recipients to enroll in employer-sponsored health insurance as a condition for eligibility until, and unless, it seeks demonstration project status for this practice and HCFA approves the necessary waiver.
Agency Affected: Department of Health and Human Services: Health Care Financing Administration
Explore the full database of GAO's Open Recommendations
»
Mar 3, 2021
-
Drug Safety:
FDA's Future Inspection Plans Need to Address Issues Presented by COVID-19 BacklogGAO-21-409T: Published: Mar 4, 2021. Publicly Released: Mar 3, 2021.
Mar 1, 2021
-
Medicare Part B:
Payments and Use for Selected New, High-Cost DrugsGAO-21-252: Published: Mar 1, 2021. Publicly Released: Mar 1, 2021.
Feb 24, 2021
-
Covid-19:
Key Insights from GAO's Oversight of the Federal Public Health ResponseGAO-21-396T: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 17, 2021
Feb 11, 2021
-
Operation Warp Speed:
Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesGAO-21-319: Published: Feb 11, 2021. Publicly Released: Feb 11, 2021.
Feb 5, 2021
-
DOD Health Care:
DOD Should Monitor Implementation of Its Clinical Practice GuidelinesGAO-21-237: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
Medicaid:
CMS Needs to Implement Risk-Based Oversight of Puerto Rico's Procurement ProcessGAO-21-229: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
VA Health Care:
Community Living Centers Were Commonly Cited for Infection Control Deficiencies Prior to the COVID-19 PandemicGAO-21-195R: Published: Jan 6, 2021. Publicly Released: Feb 5, 2021.
Jan 28, 2021
-
COVID-19:
Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal AttentionGAO-21-265: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 21, 2021
-
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021.
Looking for more? Browse all our products here